Is LLY up or down today?
LLY is down 0.35% today, last at 1,155.98. This stock moved -0.35% versus the prior close.
LLY · Lilly (Eli)
LLY (Lilly (Eli)) is trading at 1,155.98, down 0.35% on the session. Price action shows weakness or stretched conditions worth watching.
Leading the coverage: “Rothschild & Co Redburn Adjusts PT on Eli Lilly and Co. to $930 From $915, Keeps Neutral Rating” (MT Newswires, 7h ago).
Social buzz is mixed — no strong crowd signal.
Analyst firms are mostly reiterating — no strong directional shift lately.
LLY is down 0.35% today, last at 1,155.98. This stock moved -0.35% versus the prior close.
Leading the coverage: “Rothschild & Co Redburn Adjusts PT on Eli Lilly and Co. to $930 From $915, Keeps Neutral Rating” (MT Newswires, 7h ago). Dominant story: Rothschild & Co Redburn Adjusts PT on Eli Lilly and Co. to $930 From $915, Keeps Neutral Rating (1 source, neutral) RSI is 43 — leaning bearish Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (124 days) · Drag or scroll left for earlier dates
Rothschild & Co Redburn Adjusts PT on Eli Lilly and Co. to $930 From $915, Keeps Neutral Rating
Eli Lilly Unit to Make $8.6 Million Milestone Payment to Nxera Pharma
Nxera Pharma to Receive $8.6 Million Milestone Payment from Centessa Pharmaceuticals Following Late-stage Development Progress
Mounjaro Vs Trulicity: Eli Lilly’s New FDA Win Puts Its Blockbuster Weight-Loss Drug In Focus - Stocktwits
Eli Lilly Just Announced a Major Acquisition. Here's What It Means. - The Globe and Mail